Literature DB >> 12463463

TNF involvement and anti-TNF therapy of reactive and unclassified arthritis.

R Meador1, E Hsia, T Kitumnuaypong, H R Schumacher.   

Abstract

A growing body of evidence shows that tumor necrosis factor (TNF) alpha, a pro-inflammatory cytokine involved in the pathogenesis of rheumatoid arthritis (RA), is also involved in the pathogenesis of reactive and unclassified arthritis. Elevated levels of TNF-alpha and other pro-inflammatory cytokines are seen in these inflammatory arthropathies. The clinical effect on a potential underlying infection is not known, but several studies have suggested at least short-term effectiveness and safety of anti-TNF-alpha therapy in reactive and unclassified arthritis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12463463

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

Review 1.  When is arthritis reactive?

Authors:  S S Hamdulay; S J Glynne; A Keat
Journal:  Postgrad Med J       Date:  2006-07       Impact factor: 2.401

2.  Combined effects of EFA deficiency and tumor necrosis factor-alpha on circulating lipoproteins in rats.

Authors:  Emile Levy; Edgard Delvin; Noel Peretti; Guylaine Bouchard; Ernest Seidman
Journal:  Lipids       Date:  2003-06       Impact factor: 1.880

Review 3.  Successful use of etanercept for the treatment of Reiter's syndrome: a case report and review of the literature.

Authors:  Amr Edrees
Journal:  Rheumatol Int       Date:  2011-07-23       Impact factor: 3.580

Review 4.  Treatment of reactive arthritis with biological agents: a review.

Authors:  Huiqiong Zeng; Baiwei Luo; Yue Zhang; Zhongyu Xie; Zhizhong Ye
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.